Core Viewpoint - Quantum Computing Inc's stock has seen a significant increase following better-than-expected earnings, with shares rising 7.3% amid a broader market rally [1][3]. Financial Performance - The company reported third-quarter revenues of $384,000, a substantial increase from $101,000 in the same period last year, indicating a more than threefold increase in sales [2]. - Quantum Computing reduced its net loss in Q3 from $5.7 million last year to $2.4 million this year, reflecting improved financial performance [2][3]. Market Context - The stock's rise coincided with gains in the S&P 500 and Nasdaq Composite, which increased by 0.9% and 1.3%, respectively [1]. - Recent employment data has raised hopes for a potential Federal Reserve rate cut in December, which could further support speculative investments like Quantum Computing's stock [4]. Stock Metrics - Quantum Computing's current stock price is $12.34, with a market capitalization of $2 billion [2]. - The stock has experienced a 52-week range of $2.44 to $27.15, indicating significant volatility [2].

Key Points D-Wave Quantum's stock is up over 1,700% in the past 12 months. D-Wave Quantum has commercially available products, while many competitors are still in the research phase. 10 stocks we like better than D-Wave Quantum › Quantum computing is receiving increasing attention as the next major technological advancement. Even the U.S. government is considering taking equity stakes in American quantum computing companies to ensure it remains at the forefront of the technology. One company that h ...

Core Insights - 2025 has seen significant investment themes including artificial intelligence, quantum computing, and notably, nuclear energy stocks, with the VanEck Uranium and Nuclear ETF delivering a total return of 55% as of November 17 [2] Company Performance - NuScale Power experienced a tumultuous year, with shares rising nearly 200% through mid-October but subsequently collapsing by around 61% from their peak due to disappointing Q3 earnings [3][6] - The company reported a substantial loss of $1.85 per share against analyst expectations of a loss of only 11 cents, primarily due to a $128.5 million payment to ENTRA1 Energy aimed at expediting a six-gigawatt nuclear energy deployment [4][5] - Following the earnings report, NuScale's shares dropped 14% on November 6 and continued to decline, resulting in a total decrease of 45% since the report, with Royal Bank of Canada lowering its price target from $35 to $32 [5] Market Reactions - Constellation Energy, the largest operator of nuclear energy facilities in the U.S., reported Q3 earnings on November 7, missing both sales and adjusted EPS expectations, yet the stock gained 2% on the same day [7] - Despite a 16% decline from mid-October highs, Constellation has still achieved a total return of 52% year-to-date [7]

Key Points D-Wave’s share price increased by more than 1,000% over a 12-month span ranging from late 2024 through 2025. The company surpassed 100 customers and continues to grow revenue. Quantum computing’s commercial viability largely remains to be seen, but potential market size could top $100 billion in the next decade. These 10 stocks could mint the next wave of millionaires › For a second, let's assume the commercial uses for quantum computing take off spectacularly. In this hypothetical, in ...

CoreWeave - CoreWeave is not a quantum computing stock but is often associated with the sector due to its connection with NVIDIA and its AI-focused business model [3] - The company has a significant backlog of nearly $60 billion, with $50 billion in contracted remaining performance obligations (RPO) [3] - For the full year, CoreWeave expects approximately $5 billion in revenue, more than double from the previous year, but will incur $13 billion in capital expenditures (CapEx) and $1.4 billion in interest expenses [3] - The stock has seen a decline of nearly 15% due to lower-than-expected guidance for Q4 and the full year [4] - CoreWeave's growth is heavily dependent on external factors such as contractor performance and power availability [5] Rigetti Computing - Rigetti reported Q3 revenue of only $1.9 million, a decline of around 18% year-over-year, contrasting sharply with CoreWeave's nearly doubled revenue [6] - The company is in the early stages of quantum computing, with ambitious goals to deliver advanced quantum systems in the coming years [6] Rocket Lab - Rocket Lab reported record Q3 revenue of $155 million, up approximately 48% year-over-year, although it remains unprofitable [11] - The company has a backlog of 49 launches under contract, with 17 deals signed in Q3 alone [11] - Rocket Lab is affected by the government shutdown, which has delayed awards for key projects [12] AST SpaceMobile - AST SpaceMobile is building a satellite-based cellular network and has secured contracts with over 50 mobile network operators globally, covering nearly three billion subscribers [17] - The company reported just under $15 million in revenue for Q3 but has $1 billion in contracted revenue commitments [15] - AST SpaceMobile expects to launch a satellite every 1-2 months, aiming to deploy between 45 and 60 satellites by the end of next year [18]

Industry Overview - Quantum computing is rapidly emerging as a significant technology, second only to artificial intelligence, with recent advancements in computing power and error correction attracting investor and government interest [1] Company Performance - Quantum Computing (NASDAQ: QUBT), also known as QCI, has seen its stock price increase by 286% over the past 12 months, turning a $500 investment into $1,920 [2] - QCI focuses on providing manageable quantum computing solutions through software, hardware, and end-to-end services, differentiating itself from competitors that prioritize research and development [3] - In Q3, QCI reported a revenue increase of 280% year over year, reaching $384,000, with a gross margin of 33%, up from 9% the previous year [4] - A notable achievement for QCI was securing its first U.S. commercial sale of quantum cybersecurity solutions through an order from a top-five U.S. bank, indicating traction in real-world applications [4][7]

Group 1 - Jim Cramer discussed Dollar Tree, Inc. (NASDAQ:DLTR) following a downgrade by Goldman Sachs from Buy to Sell, citing concerns about lower-income consumers and competition from other discount retailers like Ollie's [1][2] - The downgrade highlights that lower-income consumers are not purchasing as much, despite Dollar Tree's low prices, which have increased recently, with many items now priced between $3 to $5 [2] - An empirical analysis from a firm called 100x indicates that customer intent is currently not favorable towards Dollar Tree, suggesting a compelling sell opportunity [2] Group 2 - While there is potential for Dollar Tree as an investment, there is a belief that certain AI stocks may offer better returns with limited downside risk [3]

We recently published 8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development. Flutter Entertainment plc (NYSE:FLUT) is one of the stocks Jim Cramer discussed. Flutter Entertainment plc (NYSE:FLUT) is one of the largest sports betting companies in the US. Cramer discussed the firm after Polymarket rang the NYSE’s opening bell. The event saw the online prediction market team up with mixed martial arts (MMA) organization UFC and entertainment firm TKO. In his previous comments a ...

We recently published 8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development. Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer discussed. Jim Cramer has turned increasingly bullish on Google’s parent Alphabet Inc. (NASDAQ:GOOGL). Over the course of several appearances, he has discussed the firm’s cloud business, the dominance of its YouTube platform, and its quantum computing business. Along with IBM, Cramer believes that Alphabet Inc. (NASDAQ:GOOGL) is a great st ...

We recently published 8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development. Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer discussed. Cramer has recently started to discuss pharmaceutical giant Amgen Inc. (NASDAQ:AMGN) more frequently. Most of his discussions surround the firm’s Repatha drug that aims to reduce cholesterol and prevent adverse cardiovascular events. In a November 11th appearance, the CNBC TV host commented that Amgen Inc. (NASDAQ:AMGN), along with ...